Journal article
Formulation of highly soluble poly(ethylene glycol)‐peptide DNA condensates
Journal of pharmaceutical sciences, Vol.88(10), pp.996-1003
10/1999
DOI: 10.1021/js990072s
PMID: 10514346
Abstract
Two poly(ethylene glycol) (PEG)‐peptides were synthesized and tested for their ability to bind to plasmid DNA and form soluble DNA condensates with reduced spontaneous gene expression. PEG‐vinyl sulfone or PEG‐orthopyridyl disulfide were reacted with the sulfhydryl of Cys‐Trp‐Lys18 (CWK18) resulting in the formation of nonreducible (PEG‐VS‐CWK18) and reducible (PEG‐SS‐CWK18) PEG‐ peptides. Both PEG‐peptides were prepared on a micromole scale, purified by RP‐HPLC in >80% yield, and characterized by 1H NMR and MALDI‐TOF. PEG‐peptides bound to plasmid DNA with an apparent affinity that was equivalent to alkylated (Alk)CWK18, resulting in DNA condensates with a mean diameter of 80–90 nm and Z (zeta) potential of +10 mV. The particle size of PEG‐peptide DNA condensates was constant throughout the DNA concentration range of 0.05–2 mg/mL, indicating these to be approximately 20‐fold more soluble than AlkCWK18 DNA condensates. The spontaneous gene transfer to HepG2 cells mediated by PEG‐VS‐CWK18 DNA conden‐ sates was over two orders of magnitude lower than PEG‐SS‐CWK18 DNA condensates and three orders of magnitude lower than AlkCWK18 DNA condensates. PEG‐VS‐CWK18 efficiently blocked in vitro gene transfer by reducing cell uptake. The results indicate that a high loading density of PEG on DNA is necessary to achieve highly soluble DNA condensates that reduce spontaneous in vitro gene transfer by blocking nonspecific uptake by HepG2 cells. These two properties are important for developing targeted gene delivery systems to be used in vivo.
Details
- Title: Subtitle
- Formulation of highly soluble poly(ethylene glycol)‐peptide DNA condensates
- Creators
- Kai Y. Kwok - University of MichiganDonald L. Mckenzie - University of MichiganDavid L. Evers - University of MichiganKevin G. Rice - University of Michigan
- Resource Type
- Journal article
- Publication Details
- Journal of pharmaceutical sciences, Vol.88(10), pp.996-1003
- DOI
- 10.1021/js990072s
- PMID
- 10514346
- NLM abbreviation
- J Pharm Sci
- ISSN
- 0022-3549
- eISSN
- 1520-6017
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 10/1999
- Academic Unit
- Pharmaceutical Sciences and Experimental Therapeutics; Craniofacial Anomalies Research Center; Medicinal and Natural Products Chemistry
- Record Identifier
- 9984366036102771
Metrics
13 Record Views